Cited by 294Sarcoma Diagnosis and TreatmentBone Tumor Diagnosis and TreatmentsOvarian cancer diagnosis and treatment

The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.

Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.

Meyers, P A, Gorlick, R, Heller, G, Casper, E, Lane, J, Huvos, A G, Healey, J H·1998·Journal of Clinical Oncology

DOI 10.1200/jco.1998.16.7.2452

Open this paper in CoChat — free account

Abstract

PURPOSE: It has been observed previously in osteosarcoma (OS) that the degree of necrosis of the resected primary tumor following a period of preoperative chemotherapy is predictive of subsequent event-free survival (EFS). The aim of this study was to determine if more intensive preoperative chemotherapy would increase the proportion of patients with a good histologic response and improve EFS. PATIENTS AND METHODS: Seventy-three patients with OS were treated at Memorial-Sloan Kettering Cancer Center (MSKCC) on the T12 protocol between 1986 and 1993. Patients were randomized between therapy based on the T10 protocol and therapy with more intensive preoperative chemotherapy. The more intensive preoperative regimen consisted of two courses of cisplatin (CDDP) and doxorubicin (DOX) in addition to the usual preoperative regimen of high-dose methotrexate (HD MTX) and bleomycin, cyclophosphamide, and dactinomycin (BCD). RESULTS: The regimen with more intensive preoperative chemotherapy achieved a modest increase in the proportion of patients with a good histologic response (44% with a grade III or IV histologic response v 37% in the control arm, 33% with grade IV histologic response v 13% in the control arm). EFS continued to correlate with histologic response. The actuarial 5-year EFS in patients with localized disease was 78% for the regimen with more intensive preoperative chemotherapy and 73% for the control arm. CONCLUSION: Despite modest increases in the proportion of patients with good histologic response with intensified preoperative chemotherapy, no improvement in EFS was observed.

Integrity signals

Registry

Crossref · 10.1200/jco.1998.16.7.2452

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Statistical Analysis of Failure Time Data.
Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875
The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the Extremity
Link, M. P., Goorin, A. M., Miser, A. W., Green, A. A., Pratt, C. B., Belasco, J. B., Pritchard, J., Malpas, J. S., Baker, A. R., Kirkpatrick, J. A., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606193142502 · Cited by 1,203
Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy
Rosen, G., Caparros, B., Huvos, A. G., Kosloff, C., Nirenberg, A., Cacavio, A., Marcove, R. C., Lane, J. M., Mehta, B. M., & Urban, C. (1982) · Cancer · doi:10.1002/1097-0142(19820315)49:6 · Cited by 1,082
Self-citation
Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.
Meyers, P. A., Heller, G., Healey, J. H., Huvos, A. G., Lane, J. M., Marcove, R. C., Applewhite, A., Vlamis, V., & Rosen, G. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.1.5 · Cited by 675
Self-citation
Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery
Rosen, G., Marcove, R. C., Caparros, B., Nirenberg, A., Kosloff, C., & Huvos, A. G. (1979) · Cancer · doi:10.1002/1097-0142(197906)43:6 · Cited by 584
Self-citation
Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial.
Eilber, F. R., Giuliano, A. E., Eckardt, J. J., Patterson, K., Moseley, S. H., & Goodnight, J. E. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.1.21 · Cited by 524
Osteogenic sarcoma. A study of six hundred cases.
Dahlin, D. C., & Coventry, M. B. (1967) · PubMed · Cited by 475
Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.
Provisor, A. J., Ettinger, L. J., Nachman, J. B., Krailo, M., Makley, J. T., Yunis, E. J., Huvos, A. G., Betcher, D. L., Baum, E. S., Kisker, C. T., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.76 · Cited by 458
Self-citation
Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.
Winkler, K., Beron, G., Delling, G., Heise, U., Kabisch, H., Purfürst, C., Berger, J., Ritter, J., Jürgens, H., & Gerein, V. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.2.329 · Cited by 457
Osteogenic sarcoma with clinically detectable metastasis at initial presentation.
Meyers, P. A., Heller, G., Healey, J. H., Huvos, A. G., Applewhite, A., Sun, M., & LaQuaglia, M. P. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.449 · Cited by 389
Self-citation

Show all 18 references

Sorted by citations

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
Isakoff, M. S., Bielack, S., Meltzer, P. S., & Gorlick, R. G. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.4895 · Cited by 1,578
Self-citation
Osteosarcoma treatment – Where do we stand? A state of the art review
Lütke, A., Meyers, P. A., Lewis, I. J., & Juergens, H. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.11.006 · Cited by 1,237
Self-citation
Biology and Therapeutic Advances for Pediatric Osteosarcoma
Marina, N. M., Gebhardt, M. C., Teot, L. A., & Gorlick, R. G. (2004) · The Oncologist · doi:10.1634/theoncologist.9-4-422 · Cited by 670
Self-citation
Osteosarcoma
Beird, H. C., Bielack, S. S., Flanagan, A. M., Gill, J., Heymann, D., Janeway, K. A., Livingston, J. A., Roberts, R. D., Strauss, S. J., & Gorlick, R. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00409-y · Cited by 660
Self-citation
Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?
Anninga, J. K., Gelderblom, H., Fiocco, M., Kroep, J. R., Taminiau, A. H. M., Hogendoorn, P. C. W., & Egeler, R. M. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.05.030 · Cited by 456
Neoadjuvant Chemotherapy With High-Dose Ifosfamide, High-Dose Methotrexate, Cisplatin, and Doxorubicin for Patients With Localized Osteosarcoma of the Extremity: A Joint Study by the Italian and Scandinavian Sarcoma Groups
Ferrari, S., Smeland, S., Mercuri, M., Bertoni, F., Longhi, A., Ruggieri, P., Alvegård, T. A., Picci, P., Capanna, R., Bernini, G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.5785 · Cited by 432
Postrelapse Survival in Osteosarcoma of the Extremities: Prognostic Factors for Long-Term Survival
Ferrari, S., Briccoli, A., Mercuri, M., Bertoni, F., Picci, P., Tienghi, A., Del Prever, A. B., Fagioli, F., Comandone, A., & Bacci, G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.141 · Cited by 316
Expression of HER2/erbB-2 Correlates With Survival in Osteosarcoma
Gorlick, R. G., Huvos, A. G., Heller, G., Aledo, A., Beardsley, G. P., Healey, J. H., & Meyers, P. A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2781 · Cited by 301
Self-citation
Metastatic osteosarcoma: a challenging multidisciplinary treatment
Meazza, C., & Scanagatta, P. (2016) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2016.1168697 · Cited by 300
Current Treatment of Osteosarcoma
Ferguson, W. S., & Goorin, A. M. (2001) · Cancer Investigation · doi:10.1081/cnv-100102557 · Cited by 294
Sarcoma
Skubitz, K. M., & D’Adamo, D. R. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.11.1409 · Cited by 283
New targets and approaches in osteosarcoma
Gill, J. B., Ahluwalia, M., Geller, D., & Gorlick, R. G. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.09.003 · Cited by 274
Self-citation
Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors
Sandberg, A. A., & Bridge, J. A. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(03)00105-5 · Cited by 261
Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate
Garbisa, S., Sartor, L., Biggin, S., Salvato, B., Benelli, R., & Albini, A. (2001) · Cancer · doi:10.1002/1097-0142(20010215)91:4 · Cited by 316
Osteosarcoma: Review of the Past, Impact on the Future. The American Experience
Jaffe, N. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_12 · Cited by 252
Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: A report from the Children's Oncology Group
Chou, A. J., Kleinerman, E. S., Krailo, M. D., Chen, Z., Betcher, D. L., Healey, J. H., Conrad, E. U., Nieder, M. L., Weiner, M. A., Wells, R. J., et al. (2009) · Cancer · doi:10.1002/cncr.24566 · Cited by 245
Self-citation
Surgical options for children with osteosarcoma
Grimer, R. J. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)01734-1 · Cited by 238
Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: initial results
Hayashida, Y., Yakushiji, T., Awai, K., Katahira, K., Nakayama, Y., Shimomura, O., Kitajima, M., Hirai, T., Yamashita, Y., & Mizuta, H. (2006) · European Radiology · doi:10.1007/s00330-006-0342-y · Cited by 209
Programmed Cell Death Ligand 1 Expression in Osteosarcoma
Shen, J. K., Cote, G. M., Choy, E., Yang, P., Harmon, D. C., Schwab, J. H., Nielsen, G. P., Chebib, I. A., Ferrone, S., Wang, X., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0224 · Cited by 200
Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: Prognostic Factors and Impact on Survival
Petrilli, A. S., de Camargo, B., Filho, V. O., Bruniera, P., Brunetto, A. L., Jesús-García, R., de Camargo, O. P., Pena, W., Baptista, P. P. R., Davi, A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.5352 · Cited by 188
Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma.
Ulaner, G. A., Huang, H.-Y., Otero, J. E., Zhao, Z., Ben‐Porat, L., Satagopan, J. M., Gorlick, R. G., Meyers, P. A., Healey, J. H., Huvos, A. G., et al. (2003) · PubMed · Cited by 181
Self-citation
Improved outcomes in patients with osteogenic sarcoma of the head and neck
Patel, S. G., Meyers, P. A., Huvos, A. G., Wolden, S. L., Singh, B., Shaha, A. R., Boyle, J. O., Pfister, D. G., Shah, J. P., & Kraus, D. H. (2002) · Cancer · doi:10.1002/cncr.10849 · Cited by 180
Self-citation
Feasibility and Response to Induction Chemotherapy Intensified With High-Dose Methotrexate for Young Children With Newly Diagnosed High-Risk Disseminated Medulloblastoma
Chi, S. N., Gardner, S. L., Levy, A., Knopp, E. A., Miller, D. C., Wisoff, J. H., Weiner, H. L., & Finlay, J. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.126 · Cited by 176
Neoadjuvant chemotherapy for osteosarcoma of the extremity
Bacci, G., Briccoli, A., Ferrari, S., Longhi, A., Mercuri, M., Capanna, R., Donati, D. M., Lari, S., Forni, C., & PAOLIS, M. D. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00229-5 · Cited by 173
SFOP OS94: A randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients
Deley, M. L., Guinebretière, J. M., Gentet, J., Pacquement, H., Pichon, F., Marec‐Bérard, P., Entz‐Werlé, N., Schmitt, C., Brugières, L., Vanel, D., et al. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2006.10.023 · Cited by 160
Mechanisms of methotrexate resistance in osteosarcoma.
Guo, W., Healey, J. H., Meyers, P. A., Ladanyi, M., Huvos, A. G., Bertino, J. R., & Gorlick, R. G. (1999) · PubMed · Cited by 152
Self-citation
National Cancer Data Base report on osteosarcoma of the head and neck
Smith, R. B., Apostolakis, L. W., Karnell, L. H., Koch, B. B., Robinson, R. A., Zhen, W. K., Menck, H. R., & Hoffman, H. T. (2003) · Cancer · doi:10.1002/cncr.11716 · Cited by 151
Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review
Daw, N. C., Chou, A. J., Jaffe, N., Rao, B. N., Billups, C. A., Galindo, C. R., Meyers, P. A., & Huh, W. W. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.585 · Cited by 149
Self-citation
Neoadjuvant Chemotherapy and Local Radiotherapy for High-Grade Osteosarcoma of the Extremities
Machak, G. N., Si, T., Solovyev, Y. N., Sinyukov, P. A., Ivanov, S. M., Кочергина, Н. В., Ryjkov, A. D., Тепляков, В. В., Bokhyan, B. Y., & Glebovskaya, V. V. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.2.147 · Cited by 149
Viable and necrotic tumor assessment from whole slide images of osteosarcoma using machine-learning and deep-learning models
Arunachalam, H. B., Mishra, R., Daescu, O., Cederberg, K., Rakheja, D., Sengupta, A. L., Leonard, D., Hallac, R. R., & Leavey, P. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210706 · Cited by 151
Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations
Suehara, Y., Alex, D., Bowman, A., Middha, S., Zehir, A., Chakravarty, D., Wang, L., Jour, G., Nafa, K., Hayashi, T., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-4032 · Cited by 135
Self-citation
High-Dose Chemotherapy in the Treatment of Relapsed Osteosarcoma: An Italian Sarcoma Group Study
Fagioli, F., Aglietta, M., Tienghi, A., Ferrari, S., del Prever, A. B., Vassallo, E., Palmero, A., Biasin, E., Bacci, G., Picci, P., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.081 · Cited by 133
Treatment of osteosarcoma at first recurrence after contemporary therapy
Chou, A. J., Merola, P. R., Wexler, L. H., Gorlick, R. G., Vyas, Y. M., Healey, J. H., LaQuaglia, M. P., Huvos, A. G., & Meyers, P. A. (2005) · Cancer · doi:10.1002/cncr.21417 · Cited by 131
Self-citation
Osteogenic and Ewing Sarcomas: Estimation of Necrotic Fraction during Induction Chemotherapy with Dynamic Contrast-enhanced MR Imaging
Dyke, J. P., Panicek, D. M., Healey, J. H., Meyers, P. A., Huvos, A. G., Schwartz, L. H., Thaler, H. T., Tofts, P. S., Gorlick, R. G., Koutcher, J. A., et al. (2003) · Radiology · doi:10.1148/radiol.2281011651 · Cited by 125
Self-citation
Reduced Argininosuccinate Synthetase Is a Predictive Biomarker for the Development of Pulmonary Metastasis in Patients with Osteosarcoma
Kobayashi, E., Masuda, M., Nakayama, R. T., Ichikawa, H., Satow, R., Shitashige, M., Honda, K., Yamaguchi, U., Shoji, A., Tochigi, N., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0774 · Cited by 122
[F‐18]‐fluorodeoxy‐D‐glucose–positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults
Hawkins, D. S., Conrad, E. U., Butrynski, J. E., Schuetze, S. M., & Eary, J. F. (2009) · Cancer · doi:10.1002/cncr.24421 · Cited by 118
Dynamic contrast‐enhanced magnetic resonance imaging as a prognostic factor in predicting event‐free and overall survival in pediatric patients with osteosarcoma
Guo, J., Reddick, W. E., Glass, J. O., Ji, Q., Billups, C. A., Wu, J., Hoffer, F. A., Kaste, S. C., Jenkins, J. J., Flores, X. C. O., et al. (2011) · Cancer · doi:10.1002/cncr.26701 · Cited by 113
Platelet‐derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma
Kubo, T., Piperdi, S., Rosenblum, J., Antonescu, C. R., Chen, W., Kim, H., Huvos, A. G., Sowers, R. S., Meyers, P. A., Healey, J. H., et al. (2008) · Cancer · doi:10.1002/cncr.23437 · Cited by 112
Self-citation
Lumbar Spine MRI for Low Back Pain: Indications and Yield
Roudsari, B. S., & Jarvik, J. G. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.10.4367 · Cited by 117
Telomerase Expression Predicts Unfavorable Outcome in Osteosarcoma
Sanders, R. P., Drissi, R., Billups, C. A., Daw, N. C., Valentine, M. B., & Dome, J. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.043 · Cited by 108
Emerging roles for long noncoding RNAs in skeletal biology and disease
Huynh, N. P. T., Anderson, B. A., Guilak, F., & McAlinden, A. (2016) · Connective Tissue Research · doi:10.1080/03008207.2016.1194406 · Cited by 105
International Collaboration is Feasible in Trials for Rare Conditions: The EURAMOS Experience
Marina, N. M., Bielack, S., Whelan, J. S., Smeland, S., Krailo, M., Sydes, M. R., Butterfaß‐Bahloul, T., Calaminus, G., & Bernstein, M. L. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_18 · Cited by 102
High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study
Peiffert, D., Giovannini, M. F., Ducreux, M. P., Michel, P., François, É., Lemanski, C., Mirabel, X., Cvitkovic, F., Luporsi, É., Conroy, T., et al. (2001) · Annals of Oncology · doi:10.1023/a:1011107105538 · Cited by 99
Dietary Nitrate Supplementation Protects Against Doxorubicin-Induced Cardiomyopathy by Improving Mitochondrial Function
Zhu, S.-G., Kukreja, R. C., Das, A., Chen, Q., Lesnefsky, E. J., & Xi, L. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.01.024 · Cited by 96
Staging of Primary Malignancies of Bone
Heck, R. K., Peabody, T. D., & Simon, M. A. (2006) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.6.366 · Cited by 96
Ornithine decarboxylase prevents methotrexate-induced apoptosis by reducing intracellular reactive oxygen species production
Huang, C. C., Hsu, P. C., Hung, Y.-C., Liao, Y. F., Liu, C. C., Hour, C. T., Kao, M.-C., Tsay, G. J., Hung, H., & Liu, G. Y. (2005) · APOPTOSIS · doi:10.1007/s10495-005-2947-z · Cited by 88
Outcome after local recurrence of osteosarcoma
Galindo, C. R., Shah, N. N., McCarville, M. B., Billups, C. A., Neel, M. N., Rao, B. N., & Daw, N. C. (2004) · Cancer · doi:10.1002/cncr.20214 · Cited by 86
Management of osteosarcoma
Whelan, J., Seddon, B. M., & Perisoglou, M. (2006) · Current Treatment Options in Oncology · doi:10.1007/s11864-006-0020-y · Cited by 84
Quality of Life Following Amputation or Limb Preservation in Patients with Lower Extremity Bone Sarcoma
Mason, G. E., Aung, L., Gall, S., Meyers, P. A., Butler, R., Krüg, S., Kim, M., Healey, J. H., & Gorlick, R. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00210 · Cited by 81
Self-citation
Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials
Eselgrim, M., Grunert, H., Kühne, T., Zoubek, A., Kevric, M., Buerger, H., Jürgens, H., Mayer‐Steinacker, R., Gosheger, G., & Bielack, S. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20608 · Cited by 79
Muramyl Tripeptide-Phosphatidyl Ethanolamine Encapsulated in Liposomes (L-MTP-PE) in the Treatment of Osteosarcoma
Meyers, P. A., & Chou, A. J. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-04843-7_17 · Cited by 79
Self-citation
Nonmetastatic Osteosarcoma of the Extremity: Results of a Neoadjuvant Chemotherapy Protocol (IOR/OS-3) with High-dose Methotrexate, Intraarterial or Intravenous Cisplatin, Doxorubicin, and Salvage Chemotherapy Based on Histologic Tumor Response
Ferrari, S., Mercuri, M., Picci, P., Bertoni, F., del Prever, A. B., Tienghi, A., Mancini, A. F., Longhi, A., Rimondini, S., Donati, D. M., et al. (1999) · Tumori Journal · doi:10.1177/030089169908500607 · Cited by 79
Magnetic resonance imaging of bone marrow in oncology, Part 2
Hwang, S., & Panicek, D. M. (2007) · Skeletal Radiology · doi:10.1007/s00256-007-0308-4 · Cited by 78
Early Equivalence of Uncemented Press-fit and Compress® Femoral Fixation
Farfalli, G. L., Boland, P. J., Morris, C. D., Athanasian, E. A., & Healey, J. H. (2009) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-009-0912-9 · Cited by 76
Self-citation
Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: decoy, trap and kill chemotherapy moves toward the clinic
Igarashi, K., Kawaguchi, K., Kiyuna, T., Miyake, K., Miyake, M., Li, S., Han, Q., Tan, Y., Zhao, M. D., Li, Y., et al. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1431596 · Cited by 75
High-Dose Methotrexate in Osteosarcoma: Let the Questions Surcease—Time for Final Acceptance
Jaffe, N., & Gorlick, R. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.7793 · Cited by 74
Self-citation
Presurgical Window of Carboplatin and Surgery and Multidrug Chemotherapy for the Treatment of Newly Diagnosed Metastatic or Unresectable Osteosarcoma: Pediatric Oncology Group Trial
Ferguson, W. S., Harris, M. B., Goorin, A. M., Gebhardt, M. C., Link, M. P., Shochat, S. J., Siegal, G. P., Devidas, M., & Grier, H. E. (2001) · The American journal of pediatric hematology/oncology · doi:10.1097/00043426-200108000-00004 · Cited by 72
Neoadjuvant Chemotherapy for Osteosarcoma of the Extremity
Bacci, G., Forni, C., Ferrari, S., Longhi, A., Bertoni, F., Mercuri, M., Donati, D. M., Capanna, R., Bernini, G., Briccoli, A., et al. (2003) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200311000-00006 · Cited by 70
The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas
Palmerini, E., Colangeli, M., Nanni, C., Fanti, S., Marchesi, E., Paioli, A., Picci, P., Cambioli, S., Donati, D. M., Cevolani, L., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3509-z · Cited by 69
The Current and Future Therapies for Human Osteosarcoma
Lamplot, J. D., Denduluri, S. K., Qin, J., Li, R., Liu, X., Zhang, H., Chen, X., Wang, N., Pratt, A., Shui, W., et al. (2013) · Current Cancer Therapy Reviews · doi:10.2174/1573394711309010006 · Cited by 67
Human osteosarcoma expresses specific ephrin profiles
Varelias, A., Koblar, S. A., Cowled, P. A., Carter, C. D., & Clayer, M. (2002) · Cancer · doi:10.1002/cncr.10749 · Cited by 67
Inhaled lipid cisplatin (ILC) in the treatment of patients with relapsed/progressive osteosarcoma metastatic to the lung
Chou, A. J., Gupta, R., Bell, M. D., O’Day, K., Meyers, P. A., & Gorlick, R. G. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24438 · Cited by 66
Self-citation
The Folate Receptor α Is Frequently Overexpressed in Osteosarcoma Samples and Plays a Role in the Uptake of the Physiologic Substrate 5-Methyltetrahydrofolate
Yang, R. R., Kolb, E. A., Qin, J., Chou, A. J., Sowers, R. S., Hoang, B. H., Healey, J. H., Huvos, A. G., Meyers, P. A., & Gorlick, R. G. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1343 · Cited by 64
Self-citation
Chemotherapy for Bone Sarcoma in Adults
Wagner, M. J., Livingston, J. A., PATEL, S. R., & Benjamin, R. S. (2016) · Journal of Oncology Practice · doi:10.1200/jop.2015.009944 · Cited by 65
Chemotherapy in head and neck osteosarcoma: Adjuvant chemotherapy improves overall survival
Chen, Y., Gokavarapu, S., Shen, Q., Liu, F., Cao, W., Ling, Y.-H., & Ji, T. (2017) · Oral Oncology · doi:10.1016/j.oraloncology.2017.08.017 · Cited by 62
The patterns of relapse in osteosarcoma: The memorial Sloan‐Kettering experience
Chi, S. N., Conklin, L. S., Qin, J., Meyers, P. A., Huvos, A. G., Healey, J. H., & Gorlick, R. G. (2003) · Pediatric Blood & Cancer · doi:10.1002/pbc.10420 · Cited by 65
Self-citation
Diffusion-Weighted MR Imaging in Musculoskeletal Radiology: Applications in Trauma, Tumors, and Inflammation
Bley, T. A., Wieben, O. E., & Uhl, M. (2009) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2009.01.005 · Cited by 64
Results of Treatment for Metastatic Osteosarcoma With Neoadjuvant Chemotherapy and Surgery
Thompson, R. C., Cheng, E. Y., Clohisy, D. R., Perentesis, J. P., Manivel, C. J., & Le, C. T. (2002) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200204000-00028 · Cited by 62
Historical Perspective on the Introduction and Use of Chemotherapy for the Treatment of Osteosarcoma
Jaffe, N. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-04843-7_1 · Cited by 61
Muramyl Tripeptide-Phosphatidyl Ethanolamine Encapsulated in Liposomes (L-MTP-PE) in the Treatment of Osteosarcoma
Meyers, P. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43032-0_11 · Cited by 61
Self-citation
Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high‐risk osteosarcoma patients
Berger, M., Grignani, G., Ferrari, S., Biasin, E., Adalberto, B. D. P., Sandra, A., Saglio, F., Aglietta, M., & Franca, F. (2009) · Cancer · doi:10.1002/cncr.24368 · Cited by 61
Recurrences following primary osteosarcoma in adolescents and adults previously treated with chemotherapy
Duffaud, F., Digue, L., Mercier, C., Dalès, J.-P., Baciuchka-Palmaro, M., Volot, F. G., Thomas, P. A., & Favre, R. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00435-0 · Cited by 58
Histologic Response of High-Grade Nonmetastatic Osteosarcoma of the Extremity to Chemotherapy
Bacci, G., Ferrari, S. M., Bertoni, F., Picci, P., Bacchini, P., Longhi, A., Donati, D. M., Forni, C., Campanacci, L., & Campanacci, M. (2001) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200105000-00024 · Cited by 57
Sequence alterations in the reduced folate carrier are observed in osteosarcoma tumor samples.
Yang, R. R., Sowers, R. S., Mazza, B., Healey, J. H., Huvos, A. G., Grier, H. E., Bernstein, M. L., Beardsley, G. P., Krailo, M., Devidas, M., et al. (2003) · PubMed · Cited by 57
Self-citation
Factors influencing survival after recurrence in osteosarcoma: A report from the Children's Oncology Group
Spraker‐Perlman, H. L., Barkauskas, D. A., Krailo, M., Meyers, P. A., Schwartz, C. L., Doski, J. J., Gorlick, R. G., Janeway, K. A., & Isakoff, M. S. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.27444 · Cited by 56
Self-citation
Adjuvant therapy of osteosarcoma—A Phase II trial
Zalupski, M. M., Rankin, C. J., Ryan, J. R., Lucas, D. R., Muler, J. H., Lanier, K. S., Budd, G. T., Biermann, J. S., Meyers, F. J., & Antman, K. H. (2004) · Cancer · doi:10.1002/cncr.20021 · Cited by 56
Over‐expression of parathyroid hormone Type 1 receptor confers an aggressive phenotype in osteosarcoma
Yang, R., Hoang, B. H., Kubo, T., Kawano, H., Chou, A. J., Sowers, R. S., Huvos, A. G., Meyers, P. A., Healey, J. H., & Gorlick, R. G. (2007) · International Journal of Cancer · doi:10.1002/ijc.22749 · Cited by 55
Self-citation
Analysis of Prognostic Factors in High-Grade Osteosarcoma of the Extremities in Children: A 15-Year Single-Institution Experience
Vásquez, L., Tarrillo, F., Oscanoa, M., Maza, I., Gerónimo, J., Paredes, G., Silva, J. M., & Sialer, L. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00022 · Cited by 55
Treatment of Metastatic Osteosarcoma With the Somatostatin Analog OncoLar: Significant Reduction of Insulin-Like Growth Factor-1 Serum Levels
Mansky, P. J., Liewehr, D. J., Steinberg, S. M., Chrousos, G. P., Avila, N. A., Long, L., Bernstein, D. B., Mackall, C. L., Hawkins, D. S., & Helman, L. J. (2002) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200208000-00007 · Cited by 55
Osteosarcoma in Pediatric Patients and Young Adults: A Single Institution Retrospective Review of Presentation, Therapy, and Outcome
Haddox, C. L., Han, G., Anijar, L., Binitie, O. T., Letson, G. D., Bui, M. M., & Reed, D. R. (2014) · Sarcoma · doi:10.1155/2014/402509 · Cited by 53
A patient-derived orthotopic xenograft (PDOX) mouse model of a cisplatinum-resistant osteosarcoma lung metastasis that was sensitive to temozolomide and trabectedin: implications for precision oncology
Igarashi, K., Murakami, T., Kawaguchi, K., Kiyuna, T., Miyake, K., Zhang, Y., Nelson, S. D., Dry, S., Li, Y., Yanagawa, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19095 · Cited by 54
Treatment algorithm for locally recurrent osteosarcoma based on local disease‐free interval and the presence of lung metastasis
Nathan, S. S., Gorlick, R. G., Bukata, S. V., Chou, A. J., Morris, C. D., Boland, P. J., Huvos, A. G., Meyers, P. A., & Healey, J. H. (2006) · Cancer · doi:10.1002/cncr.22197 · Cited by 54
Self-citation
Chemotherapy for osteosarcoma – Where does it come from? What is it? Where is it going?
Yamamoto, N., & Tsuchiya, H. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.827171 · Cited by 54
mRNA expression levels of E2F transcription factors correlate with dihydrofolate reductase, reduced folate carrier, and thymidylate synthase mRNA expression in osteosarcoma.
Sowers, R. S., Toguchida, J., Qin, J., Meyers, P. A., Healey, J. H., Huvos, A. G., Banerjee, D., Bertino, J. R., & Gorlick, R. G. (2003) · PubMed · Cited by 53
Self-citation
Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG‐782 and INT0133—A Report From the Children's Oncology Group Bone Tumor Committee
Bishop, M. W., Chang, Y., Krailo, M. D., Meyers, P. A., Provisor, A. J., Schwartz, C. L., Marina, N. M., Teot, L. A., Gebhardt, M. C., Gorlick, R., et al. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26034 · Cited by 52
Self-citation
Prognostic significance of immunohistochemical expression of ezrin in non‐metastatic high‐grade osteosarcoma
Ferrari, S., Zanella, L., Alberghini, M., Palmerini, E., Staals, E. L., & Bacchini, P. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.21360 · Cited by 52
The Synergistic Anticancer Effect of Artesunate Combined with Allicin in Osteosarcoma Cell Line in Vitro and in Vivo
Jiang, W., Huang, Y., Wang, J.-P., Yu, X., & Lin-yi, Z. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.8.4615 · Cited by 52
Reduced folate carrier protein expression in osteosarcoma
Ifergan, I., Meller, I., Isakov, J., & Assaraf, Y. G. (2003) · Cancer · doi:10.1002/cncr.11741 · Cited by 51
Evolving gene therapy approaches for osteosarcoma using viral vectors: Review
Witlox, A. M. A., Lamfers, M. L. M., Wuisman, P. I. J. M., Curiel, D. T., & Siegal, G. P. (2007) · Bone · doi:10.1016/j.bone.2006.10.017 · Cited by 53
18F-FDG Uptake During Early Adjuvant Chemotherapy Predicts Histologic Response in Pediatric and Young Adult Patients with Osteosarcoma
Davis, J. C., Daw, N. C., Navid, F., Billups, C. A., Wu, J., Bahrami, A., Jenkins, J. J., Snyder, S. E., Reddick, W. E., Santana, V. M., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.190595 · Cited by 50
The role of caspases in methotrexate-induced gastrointestinal toxicity
Papaconstantinou, H. T., Xie, C., Zhang, W., Ansari, N. H., Hellmich, M. R., Townsend, C. M., & Ko, T. C. (2001) · Surgery · doi:10.1067/msy.2001.117376 · Cited by 49
Delaying surgery with chemotherapy for osteosarcoma of the extremities
Bielack, S., Machatschek, J.-N., Flege, S., & Jürgens, H. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.6.1243 · Cited by 48
Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan
Kudawara, I., Aoki, Y., Ueda, T., Araki, N., Naka, N., Nakanishi, H., Matsumine, A., Ieguchi, M., Mori, S., Myoui, A., et al. (2013) · Journal of Chemotherapy · doi:10.1179/1973947812y.0000000055 · Cited by 48
A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcoma
Voûte, P. A., Souhami, R. L., Nooij, M. A., Somers, R., Cortés-Funes, H., van der Eijken, J. W., Pringle, J. A. S., Hogendoorn, P. C. W., Kirkpatrick, A., Uscinska, B., et al. (1999) · Annals of Oncology · doi:10.1023/a:1008361612767 · Cited by 48
Biomarkers in osteosarcoma
Kong, C., & Hansen, M. F. (2008) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530050802608496 · Cited by 47
Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: Mechanisms and implications
Xi, L., Zhu, S., Das, A., Chen, Q., Durrant, D., Hobbs, D. C., Lesnefsky, E. J., & Kukreja, R. C. (2012) · Nitric Oxide · doi:10.1016/j.niox.2012.03.006 · Cited by 47
Methotrexate for high-grade osteosarcoma in children and young adults
van Dalen, E. C., van As, J. W., & de Camargo, B. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006325.pub3 · Cited by 47
Metachronous Skeletal Osteosarcoma in Patients Treated with Adjuvant and Neoadjuvant Chemotherapy for Nonmetastatic Osteosarcoma
Aung, L., Gorlick, R. G., Healey, J. H., Shi, W., Thaler, H. T., Shorter, N. A., Huvos, A. G., & Meyers, P. A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.177 · Cited by 47
Self-citation
Outcome of surgical treatment of pelvic osteosarcoma
Guo, W., Sun, X., Ji, T., & Tang, X. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23076 · Cited by 46
Osteosarcoma of head and neck: A retrospective study on prognostic factors from a single institute database
Chen, Y., Shen, Q., Gokavarapu, S., Lin, C., Yahiya, Cao, W., Chauhan, S., Liu, Z., Ji, T., & Tian, Z. (2016) · Oral Oncology · doi:10.1016/j.oraloncology.2016.04.008 · Cited by 46

Authors: Meyers, P. A., Gorlick, R., Heller, G., Casper, E., Lane, J., Huvos, A. G., & Healey, J. H.
Affiliations: Memorial Sloan Kettering Cancer Center (US)
ORCID: Meyers, P A
Gorlick, R
Heller, G
Lane, J
Healey, J H
Venue: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Published: 1998-07
Volume: 16
Issue: 7
Pages: 2452-2458
ISSN: 0732-183X (ISSN-L)
1527-7755
DOI: 10.1200/jco.1998.16.7.2452
OpenAlex: W1946181835
Cited by: 294
References: 18
Citations by year: 2025: 1 · 2024: 3 · 2023: 6 · 2022: 5 · 2021: 6 · 2020: 9 · 2019: 6 · 2018: 7 · 2017: 10 · 2016: 11 · 2015: 15 · 2014: 22 · 2013: 16 · 2012: 8
FWCI: 7.03
Type: journal article
Language: en
Open access: closed
Locations: Journal of Clinical Oncology (publishedVersion)
PubMed (publishedVersion)
Funders: Memorial Sloan-Kettering Cancer Center
National Cancer Institute (CA-09512, T32CA009512)
Topics: Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone Tumor Diagnosis and Treatments
Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
Keywords: osteosarcoma, neoadjuvant chemotherapy, chemotherapy intensification, cisplatin, doxorubicin, high-dose methotrexate, bleomycin, cyclophosphamide, actinomycin D, histological response, tumor necrosis, event-free survival
MeSH terms: Adolescent, Adult, Antineoplastic Combined Chemotherapy Protocols, Bleomycin, Bone Neoplasms, Child, Child, Preschool, Cisplatin, Cyclophosphamide, Dactinomycin, Doxorubicin, Female, Humans, Male, Methotrexate, Necrosis, Osteosarcoma, Time Factors, Treatment Outcome, Chemotherapy, Adjuvant, Disease-Free Survival

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks